Glenn Kl Van Daele, Heir

Title: Glenn Kl Van Daele: Innovator in Gastrointestinal Motility

Introduction

Glenn Kl Van Daele is a notable inventor based in Turnhout, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the area of gastrointestinal motility. His work has implications for the treatment of conditions related to decreased peristalsis in warm-blooded animals.

Latest Patents

Glenn Kl Van Daele holds a patent for N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran, and N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin) carboxamide derivatives. This patent also covers their N-oxide forms and pharmaceutically acceptable salts that possess gastrointestinal motility stimulating properties. The compositions containing these compounds serve as active ingredients and provide methods for treating warm-blooded animals suffering from decreased gastrointestinal peristalsis. He has 1 patent to his name.

Career Highlights

Glenn is associated with Janssen Pharmaceutica N.V., a prominent company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative solutions for gastrointestinal issues, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Glenn has collaborated with notable individuals such as Georges H Van Daele, who is now deceased, and Frans M Van Den Keybus. These collaborations have enriched his research and development efforts in the pharmaceutical field.

Conclusion

Glenn Kl Van Daele is a distinguished inventor whose work has made a significant impact on gastrointestinal health. His innovative patent and contributions to Janssen Pharmaceutica N.V. highlight his commitment to advancing medical science.